Donor-Specific Allograft Tolerance by Administration of Recipient-Derived Immature Dendritic Cells and Suboptimal Immunosuppression
- 1 April 2005
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 79 (8), 969-972
- https://doi.org/10.1097/01.tp.0000158277.50073.35
Abstract
We recently showed that injection of recipient-type immature bone marrow-derived dendritic cells (iBMDCs) the day before transplantation induced a significant prolongation of allograft survival. This study aimed at improving the administration protocol to induce allograft tolerance. Various amounts of iBMDCs were administered to syngeneic LEW.1A rats before and after transplantation of an allogeneic LEW.1W heart, with or without additional suboptimal immunosuppression. Allograft survival was not improved by repeated injections of syngeneic iBMDCs or by additional treatment with low-dose rapamycin. Combining injections of iBMDCs and LF 15-0195 showed a striking synergistic effect and induced definitive allograft acceptance in 92% of recipients. Tolerant recipients accepted donor-type, but not third-party type skin grafts, suggesting the development of regulatory mechanisms capable of maintaining donor-specific tolerance. The reported findings may contribute to the development of new therapeutic strategies to induce transplantation tolerance in humans.Keywords
This publication has 18 references indexed in Scilit:
- Prolongation of Heart Allograft Survival by Immature Dendritic Cells Generated from Recipient Type Bone Marrow ProgenitorsAmerican Journal of Transplantation, 2005
- Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection1Transplantation, 2003
- LF15-0195 generates tolerogenic dendritic cells by suppression of NF-κB signaling through inhibition of IKK activityJournal of Leukocyte Biology, 2003
- Rapamycin inhibits IL-4—induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivoBlood, 2003
- Synergistic tolerance induced by LF15-0195 and anti-CD45RB monoclonal antibody through suppressive dendritic cells1Transplantation, 2003
- Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survivalTransplantation, 2003
- Induction of Donor‐Specific Allograft Tolerance by Short‐Term Treatment with LF15‐0195 After Transplantation. Evidence for a Direct Effect on T‐Cell DifferentiationAmerican Journal of Transplantation, 2002
- Cutting Edge: Recipient MHC Class II Expression Is Required to Achieve Long-Term Survival of Murine Cardiac Allografts After Costimulatory BlockadeThe Journal of Immunology, 2001
- Induction of Transplant Tolerance with Immunodominant Allopeptide-pulsed Host Lymphoid and Myeloid Dendritic CellsAmerican Journal of Transplantation, 2001
- Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat.Proceedings of the National Academy of Sciences of the United States of America, 1992